Suven Pharmaceuticals Limited

NSE:SUVENPHAR.NS

1239.8 (INR) • At close October 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q12018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 0504.9887,535575.767-4,869.49648.028-4,123.004665.701-5,257.862445.638-2,293.932173.378-1,877.7671.822-876.308121.453-443.624116.953-198.405109.03
Short Term Investments 07,738.95506,562.69,738.984,224.2798,246.0083,457.30310,515.7244,812.2244,587.8642,120.5543,755.521,805.9381,752.616754.883887.248306.761396.8170.638
Cash and Short Term Investments 8,211.2678,243.9437,5357,138.3674,869.494,872.3074,123.0044,123.0045,257.8625,257.8622,293.9322,293.9321,877.761,877.76876.308876.336443.624423.714198.405179.668
Net Receivables 01,344.91,2641,371.64401,111.32201,113.18403,172.72201,640.97301,759.13501,058.40201,744.03202,112.253
Inventory 02,311.9572,5322,714.62903,128.10503,183.07902,834.17302,646.22702,010.80401,974.88101,748.72301,570.982
Other Current Assets 0731.0630466.0470998.7240805.687014.5630717.21400.1530880.0260-0.002034.439
Total Current Assets 8,211.26712,631.86311,33111,690.6874,869.4910,110.4584,123.0049,224.9545,257.86211,279.322,293.9327,298.3461,877.765,647.852876.3084,789.645443.6243,916.467198.4053,897.342
Non-Current Assets:
Property, Plant & Equipment, Net 07,867.767,8277,612.45507,662.24906,948.33705,619.51305,534.105,348.89605,040.97304,556.5303,792.808
Goodwill 0602.58360300602.58300000000000000
Intangible Assets 0619.25717620.2110621.9020623.053022.364024.35025.904026.018027.96026.851
Goodwill and Intangible Assets 0619.257620620.2110621.9020623.053022.364024.35025.904026.018027.96026.851
Long Term Investments 01,399.6140-5,323.45101,170.96601,170.96601,170.96603,658.81401,853.93602,557.70202,815.2790-26.191
Tax Assets 044.76106,562.872059.344059.8950203.711052.02601,808.1420755.5030000
Other Non-Current Assets -8,211.267-22.3980134.96-4,869.4932.519-4,123.00432.952-5,257.862-0.001-2,293.93257.582-1,877.7659.921-876.30813.633-443.624411.869-198.405139.353
Total Non-Current Assets -8,211.2679,909.0029,2489,507.047-4,869.499,546.98-4,123.0048,835.203-5,257.8627,016.553-2,293.9329,326.872-1,877.769,096.799-876.3088,393.829-443.6247,811.638-198.4053,932.821
Total Assets 022,540.86520,57921,197.734019,657.438018,060.157018,295.873016,625.218014,744.651013,183.474011,728.10507,830.163
Liabilities & Equity:
Current Liabilities:
Account Payables 0423.574420425.9390651.6430855.55901,059.0070982.1480829.3130802.9160710.5570535.749
Short Term Debt 0437.6080499.190650.7680707.4030682.2390945.4301,067.0580976.9340944.4210827.936
Tax Payables 0003.98502.9390130.752036.422012.721000135.807052.53601.096
Deferred Revenue 06.8870149.5750255.720423.5060340.7040292.350278.5450358.7260309.6530159.691
Other Current Liabilities 0200.888049.081029.5270178.408020.99069.896022.564026.006039.084052.711
Total Current Liabilities 01,068.9574201,123.78501,587.65802,164.87602,102.9402,289.82402,197.4802,164.58202,003.71501,576.087
Non-Current Liabilities:
Long Term Debt 0212.3563458.678052.640207.3930289.0330361.340363.2990559.8440917.64400
Deferred Revenue Non-Current 0-0000128.5930296.0780373.3490417.2540000083.14600
Deferred Tax Liabilities Non-Current 0647.9120619.0610582.3460563.240543.1510332.4840309.3290276.3720275.9720291.717
Other Non-Current Liabilities -20,506.635105.004092.1720-45.6420-201.9860-284.4040-350.794066.46083.14600.001059.453
Total Non-Current Liabilities -20,506.635965.272345719.9110717.9370864.7250921.1290760.2840739.0880919.36201,276.7630351.17
Total Liabilities -20,506.6352,034.2297651,843.69602,305.59503,029.60103,024.06903,050.10802,936.56803,083.94403,280.47801,927.257
Equity:
Preferred Stock 00000000000000000000
Common Stock 0254.56519,814254.5650254.5650254.5650254.5650254.5650254.5650254.5650127.2820127.282
Retained Earnings 017,651.1800014,651.60600012,727.0860009,364.9260006,154.44303,909.835
Accumulated Other Comprehensive Income/Loss 20,506.6351,505.152019,099.47317,351.8431,349.93415,030.55614,775.99115,271.8041,194.41413,575.1113,320.54511,808.0831,350.30310,099.539,844.9658,447.627150.1145,902.9060
Other Total Stockholders Equity 01,095.7380001,095.7380001,095.738000838.2890002,015.78801,865.788
Total Shareholders Equity 20,506.63520,506.63519,81419,354.03817,351.84317,351.84315,030.55615,030.55615,271.80415,271.80313,575.1113,575.1111,808.08311,808.08310,099.5310,099.538,447.6278,447.6275,902.9065,902.905
Total Equity 20,506.63520,506.63519,81419,354.03817,351.84317,351.84315,030.55615,030.55615,271.80415,271.80313,575.1113,575.1111,808.08311,808.08310,099.5310,099.538,447.6278,447.6275,902.9065,902.905
Total Liabilities & Shareholders Equity 022,540.86520,57921,197.73417,351.84319,657.43815,030.55618,060.15715,271.80418,295.87213,575.1116,625.21811,808.08314,744.65110,099.5313,183.4748,447.62711,728.1055,902.9067,830.162